Blue wolf capital to acquire civco radiotherapy from roper technologies

New york--(business wire)--blue wolf capital partners llc (“blue wolf”), a new york-based private equity firm, today announced it has entered into an agreement to acquire civco radiotherapy, a global leader of radiotherapy patient positioning and immobilization equipment, from roper technologies, inc. (nyse: rop). with a nearly 40-year operating history and a track record of quality and reliability, civco radiotherapy serves a blue-chip customer base of academic and community hospitals, cancer
ROP Ratings Summary
ROP Quant Ranking